This Report proposes Guidance to help IOSCO members address the risk of conflicts of interest and associated conduct risks during the debt capital raising process.
IOSCO
1 September 2020
Official and private sector participants discuss effectiveness of COVID-related financial policy measures.
16 January 2020
IOSCO Recommendation: Market Authorities should consider requiring Trading Venues and their participants within their jurisdiction to synchronise, consistent with industry standards, the business clocks they use to record the date and time of any reportable event. Where they do so, business clocks should be synchronised to Coordinated Universal Time (UTC).
Drawing on established national and regional regimes for measuring, collecting and analysing information related to leverage in funds, IOSCO has developed a two-step framework – the “Leverage Framework' – to facilitate more meaningful monitoring of leverage in funds for financial stability purposes in a consistent manner across jurisdictions.
9 October 2019
Focused guidance on governance arrangements for data elements of critical OTC derivatives
19 November 2018
A post-implementation evaluation of the effects of the G20 financial regulatory reforms.
19 November 2018
An overview of responses to the August 2018.
19 November 2018
Standard-setters publish final report on evaluation of the effects of the G20 reforms on incentives to centrally clear OTC derivatives.
19 September 2018
The guidance identifies and promotes regulatory approaches that can enhance the protection of retail investors in the area of OTC leveraged products offered and sold to retail investors.
18 September 2018
Guidance to address the identified risks and the potential harm caused by specific, existing conflicts of interest and associated misconduct which can arise during the equity capital raising process.